People

The Utrecht Centre consists of staff members, professional PhDs and research fellows. 

Staff

• 

  prof. dr. M.L. De Bruin

  Professor

  Email: m.l.debruin@uu.nl
• 

  prof. dr. A.K. (Aukje) Mantel-Teeuwisse

  Professor

  Email: a.k.mantel@uu.nl
• 

  prof. dr. ir. W.G. (Wim) Goettsch

  Professor

  Email: w.g.goettsch@uu.nl
• 

  dr. H.A. (Rianne) van den Ham

  Assistant Professor

  Email: h.a.vandenham@uu.nl
• 

  dr. C. (Christine) Leopold

  Assistant Professor

  Email: c.leopold@uu.nl
• 

  dr. ir. A.M.G. (Marjon) Pasmooij

  Associate Professor

  Email: a.m.g.pasmooij@uu.nl

Past Visting Scholars

• 

  Barbara Mintzes

• 

  Fatima Suleman

Emeritus professors

• 

  prof. dr. H.G.M. (Bert) Leufkens

  Emeritus Professor

  Email: h.g.m.leufkens@uu.nl

Post-docs

• 

  dr. I.R. (Iris) Joosse

  Researcher

  Email: i.r.joosse@uu.nl
• 

  dr. J.M. (Joyce) Hoek

  Researcher

  Email: j.m.hoek@uu.nl
• 

  S.Y.I. (Saif) Elayan PhD

  Researcher

  Email: s.y.i.elayan@uu.nl

PhD students

• 

  F. (Francine) Brinkhuis MSc

  PhD Candidate

  Email: f.brinkhuis@uu.nl
• 

  I.T. (Ivar) van der Zee MSc

  PhD Candidate

  Email: i.t.vanderzee@uu.nl
• 

  J. (Jan-Willem) Versteeg MSc

  Email: j.versteeg@uu.nl
• 

  J. (Jelle) Stoelinga MSc

  PhD Candidate

  Email:
• 

  O.C. (Olivia) Lewis

  PhD Candidate

  Email: o.c.lewis@uu.nl
• 

  M. (Moska) Hellamand

  PhD Candidate

  Email: m.hellamand@uu.nl
• 

  S.C.M. (Sharon) Essink MSc

  PhD Candidate

  Email: s.c.m.essink@uu.nl

Professional PhD's

• Eriona Petro

• Lorraine Molepo

• Vlad Mixich

• Doerine Postma

• Kirti Narsai

• Washington Samukange

• Swathi Iyengar

• Comfort Ogar

• David Tordrup

• Sini Eskola

• Shui Ling Wong

• Anne Willemsen

• Martina Galotti

• Kagan Atikeler

• Ella van Vliet

Alumni

• Victoria Abbing-Karahagopian (2016)

• Thesis title: Understanding differences in findings from pharmacoepidemiological studies: The case of antidepressant and benzodiazepine use and hip fracture
  

• Tom Achoki (2016)

• Thesis title: Revisiting Health System Performance Assessment in Africa
  

• Ali Alsamil (2022)

• Thesis title: Quality of biopharmaceuticals: Comparability exercise and post-approval surveillance
  

• Daniel Ankrah (2017)

• Thesis title: Pharmaceutical policies and access to medicines: a hospital-pharmacy perspective from Ghana
  

• Lourens Bloem (2021)

• Thesis title: Evidence generation on benefits and risks of medicines and its impact on regulatory and downstream decision-making
  

• Sander van der Bogert (2017)

• Thesis title: Trials & Tribulations: Studies on the fate, transparency and efficiency of clinical drug trials
  

• Marieke De Bruin (2004)

• Thesis title: Drug-Induced Arrhythmias, Quantifying the problem

• Marcelien Callenbach (2025)

• Thesis title:Fertile Grounds for Outcome-based Managed Entry Agreements?

• Alexandra Cameron (2013)

• Thesis title: Understanding access to medicines in low- and middle-income countries through the use of price and availability indicators

• Delphi Coppens (2020)

• Thesis title: Regulating gene and cell-based therapies as medicinal products
  

• Enrico Costa (2024)

• Thesis title: Globalization of orphan drug development: integrating science, regulation, and access
  

• Ruben Duijnhoven (2016)

• Thesis title: Assessing long-term and rare adverse effects of medicines
  

• Hans Ebbers (2012)

• Thesis title: Biopharmaceuticals as Challenges to the Regulatory System

• Stefan Florentinus (2006)

• Thesis title: New drugs in general practice: prescribing patterns and external influences

• Thijs Giezen (2011)

• Thesis title: Risk management of biologicals: a regulatory and clinical perspective

• Luther Gwaza (2016)

• Thesis title: Adjusted indirect treatment comparisons of bioequivalence studies
  

• Rianne van den Ham (2016)

• Thesis title: Benefits and risks for the individual, anticoagulation for patients with atrial fibrillation
  

• Renske ten Ham (2021)

• Thesis title: Development, market authorization and market access of gene and cell-based therapies
  

• Francisco Hernandez (2015)

• Thesis title: Trust in the pharmaceutical sector: Analysis of drug safety controversies by means of drug life cycles
  

• Harald Heemstra (2010)

• Thesis title: From research on rare diseases to new orphan drug development

• Joelle Hoebert (2013)

• Thesis title: Cross country variation in medicines use. A pharmaceutical system perspective
  

• Milou Hogervorst (2023)

• Thesis title: On The Edge Of HTA: Shaping the boundaries across borders and stakeholders to prepare HTA for future complex medicines
  

• Verica Ivanovska (2017)

• Thesis title: Priority medicines for children: Exploring age-appropriate medicines and antibiotic use in children
  

• Li Jiu (2020)

• Thesis title: Innovating Health Technology Assessment Methods: Barriers and Enablers illustrated using Qualitative and Quantitative Methods on Real-World Data
  

• Iris Joosse (2024)

• Thesis title: Forging new paths in access to medicines research: Towards equitable access for all
  

• Rachel Kalf (2021)

• Thesis title: Social media as a tool for assessing patient perspectives on quality of life in metastatic melanoma: A feasibility study 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis
  

• Denis Kibira (2021)

• Thesis title: Access to sexual and reproductive health medicines and supplies in Sub-Saharan Africa
  

• Sarah Kleijnen (2016)

• Thesis title: Harmonising relative effectiveness assessments of medicines in Europe
  

• Kevin Klein (2019)

• Thesis title: Regulation in the Dynamic Environment of Complex Medicines
  

• Corinne Klop (2016)

• Thesis title: Patients at increased fracture risk: identification and pharmacological treatment
  

• Zuzana Kusynova (2023)

• Thesis title: The role of science, practice and education in building capacity for pharmacy and pharmaceutical sciences

• Joris Langedijk (2016)

• Thesis title: Continuous innovation in the drug life cycle
  

• Christine Leopold (2014)

• Thesis title: Pharmaceutical policy analysis – A European perspective on pricing and reimbursement in challenging times
  

• Johan van Luijn (2010)

• Thesis title: Comparative Information on New Medicines; availability, quality and usage

• Amr Makady (2018)

• Thesis title: Real-World Evidence for Health Technology Assessment of Pharmaceuticals: Opportunities and Challenges
  

• Aukje Mantel-Teeuwisse (2004)

• Thesis title: Quality and safety aspects of lipid-lowering drug use

• Lotte Minnema (2021)

• Thesis title: Post-marketing safety learning for biologicals: regulatory and clinical insights
  

• Gaby Ooms (2023)

• Thesis title: Contextualising access to essential medicines: Lessons learned from East and Southern Africa
  

• Armina Padmasawitri

• Thesis title:
  Methodological Approachesto Manage Challenges to the Implementation of HTA and Economic Evaluations in Low and Middle-Income Countries (LMICs)

• Eugène van Puijenbroek (2001)

• Thesis title: Quantitative Signal Detection in Pharmacovigilance

• Michelle Putzeist (2013)

• Thesis title: Marketing authorisation of new medicines in the EU: towards evidence-based improvement
  

• Yared Santa Ana Tellez (2016)

• Thesis title: Evaluating pharmaceutical policies using cross-national comparisons and time series analysis
  

• Per Sindahl (2025)

• Thesis title: Evaluating and Identifying Characteristics of Effective Risk Minimisation Measures
  

• Peter Stephens (2015)

• Thesis title: Access to Medicines: Common problems, common solutions?
  

• Pieter Stolk (2008)

• Thesis title: From molecules to new leads for innovation - Studies on the Post-Innovation Learning Cycle for Pharmaceuticals

• Giovanni Tafuri (2013)

• Thesis title: Exploring the regulatory decision-making process for medicines
  

• Y Taghipour Bazargani (2016)

• Thesis title: Access to essential medicines in low and middle income countries
  

• Niels Vermeer (2015)

• Thesis title: Pharmacovigilance of biologicals: dynamics in post-approval safety learning
  

• Marjolein Vranken (2019)

• Thesis title: Appropriate access to opioid medicines -
  A legal & policy perspective.

• Rick Vreman (2020)

• Thesis title: Health Technology Assessment Throughout the Drug Lifecycle
  

• Tina Wang (2023)

• Thesis title: Knowing me, knowing you: the evolution of HTA practice and approaches from the perspectives of HTA Agencies and pharmaceutical industry
  

• Brenda Waning (2011)

• Thesis title: Innovative Approaches for Pharmaceutical Policy Research in Developing Countries: The View Through a Market Lens

• Miriam Warnier (2014)

• Thesis title: Disease and drug-induced arrhythmias : the example of obstructive pulmonary disease
  

• Marjolein Willemen (2011)

• Thesis title: The context of medicines’ use in benefit-risk evaluation